Imperial College London


Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Wynn Chair in Human Metabolism (Clinical)



+44 (0)20 7594 1796nick.oliver




7S7aCommonwealth BuildingHammersmith Campus





Nick is the Wynn professor of human metabolism and is a consultant in diabetes and endocrinology at Imperial College Healthcare NHS Trust. His clinical and academic interest is how technologies can be developed and applied to meet the challenges of living with type 1 diabetes.



Oliver N, 2021, Holding steady, Diabetic Medicine, Vol:38, ISSN:0742-3071

Rilstone S, Reddy M, Oliver N, 2021, A Pilot Study of Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults with Type 1 Diabetes (FIRST1D)., J Diabetes Sci Technol, Vol:15, Pages:666-671

Oliver N, 2021, Best foot forward, Diabetic Medicine, Vol:38, ISSN:0742-3071

von Herrath M, Bain SC, Bode B, et al., 2021, Anti-interleukin-21 antibody and liraglutide for the preservation of beta-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial, Lancet Diabetes & Endocrinology, Vol:9, ISSN:2213-8587, Pages:212-224

Avari P, Leal Y, Herrero Vinas P, et al., 2021, Safety and feasibility of the PEPPER adaptive bolus advisor and safety system; a randomized control study, Diabetes Technology and Therapeutics, Vol:23, ISSN:1520-9156, Pages:175-186

More Publications